Delirium remains one of the most complex syndromes encountered in clinical neuroscience, characterized by acute and fluctuating disturbances in attention, cognition, and consciousness. Despite its prevalence, especially among elderly and critically ill patients, the underlying mechanisms of delirium have largely eluded researchers. Addressing this gap, the recent narrative review by Barichello et al. in Translational Psychiatry presents an exhaustive evaluation of animal models used to investigate delirium, heralding a breakthrough in the way this enigmatic condition is studied and understood at the molecular and system levels.
The review begins by emphasizing the imperative role animal models play in neuroscience research, particularly for neuropsychiatric syndromes such as delirium that are difficult to replicate and study in humans due to ethical, practical, and technical constraints. These models provide a vital platform for dissecting the neuropathophysiological pathways, allowing controlled experimental manipulation and longitudinal observation, which are otherwise impossible in patient populations. Barichello and colleagues have meticulously combed through a wide variety of such models, dissecting their strengths and limitations critically.
Central to their discussion is the diversity of methodological approaches adopted in the quest to mimic delirium’s complex clinical presentation. These models primarily involve the induction of systemic inflammation, neuroinflammation, neurotransmitter imbalances, and acute brain insults that trigger delirium-like cognitive impairments in rodents. By integrating multiple approaches such as lipopolysaccharide-induced sepsis models, surgery and anesthesia paradigms, and pharmacological interventions, the authors illuminate the multifactorial etiology of delirium. This multifaceted replication underscores the syndrome’s heterogeneous nature, which cannot be attributed to singular causative pathways.
Moreover, the review highlights the intricate role of neuroinflammation in delirium pathogenesis, a concept increasingly supported by contemporary research. Animal models that induce peripheral immune activation demonstrate robust neuroinflammatory responses, mimicking the cytokine storms and blood-brain barrier disruptions observed clinically. This neuroimmune crosstalk appears pivotal in precipitating the acute neuronal dysfunction characteristic of delirium, and the animal models provide critical insight into these temporal dynamics, potentially guiding future targeted therapies.
Importantly, Barichello et al. explore the influence of neurotransmitter systems, particularly cholinergic, dopaminergic, and GABAergic pathways, which have long been implicated in delirium’s clinical symptomatology. Experimental models utilizing pharmacological agents to disrupt these neurotransmitter systems successfully recapitulate the attentional deficits and cognitive fluctuations that typify delirium. This evidence bolsters the neurochemical hypothesis and offers a valuable platform for testing novel pharmacotherapies aimed at rebalancing these disrupted neuronal circuits.
Another key contribution of the review is the assessment of the limitations and translational barriers inherent in current animal models. The authors caution that while these models capture specific facets of delirium, none fully encapsulate its entire clinical complexity—particularly the fluctuating nature of symptoms and multifactorial triggers. Variability in species, experimental conditions, and outcome measures further complicates the translation of findings into human clinical practice. This reflection prompts a call for the refinement and standardization of model protocols to better replicate human delirium and accelerate translational validity.
The narrative further discusses the emerging frontiers in delirium animal modeling, including the advent of genetically modified rodent strains that allow the dissection of genetic predispositions and molecular pathways underlying delirium susceptibility. The integration of advanced neuroimaging and electrophysiological techniques in these models opens new avenues for elucidating real-time brain dynamics during delirium episodes. Such innovative approaches promise to unravel the neural circuitry disruptions and cognitive impairments with unprecedented resolution.
Crucially, this review also contemplates the role of age and comorbidities, noting that most animal models employ young, healthy rodents, which may not accurately reflect the vulnerable aging human brain afflicted by delirium. The authors advocate for the implementation of models incorporating geriatric rodents and comorbid conditions such as preexisting cognitive impairment or systemic illnesses, thereby enhancing the ecological validity and clinical translatability of research findings.
Barichello and colleagues underscore the importance of behavioral paradigms employed to detect delirium-like states in animals. They delve into the nuances of cognitive testing, spotlighting tasks that assess attention, memory, and executive function—domains prominently impaired in delirium. The challenge remains to develop and validate behavioral assays sensitive to the fluctuating cognitive status that hallmark human delirium, a crucial step to phenotypic fidelity in preclinical studies.
Furthermore, the review examines the temporal aspects of delirium modeling, differentiating between acute delirium states and prolonged cognitive deficits resembling post-delirium cognitive decline seen clinically. Investigating the longitudinal effects of acute insults in animal models allows the exploration of the trajectory from transient delirium to lasting neural and cognitive sequelae, thus bridging an important knowledge gap regarding the syndrome’s progression and long-term impact.
The implications of this review reach far beyond academic discourse, directly informing therapeutic innovation. By providing a consolidated framework of existing models and their mechanistic insights, this work enhances the strategic deployment of preclinical testing platforms to screen candidate drugs, identify biomarkers, and optimize therapeutic timing. This is particularly relevant given the current absence of effective delirium-specific treatments and the substantial morbidity and mortality associated with the syndrome worldwide.
In addition to neurobiological mechanisms, Barichello et al. highlight systemic physiological contributors such as hypoxia, metabolic disturbances, and hormonal imbalances modeled in animals which synergistically provoke delirium states. This holistic perspective promotes a systems biology approach, recognizing delirium as a complex interplay between central nervous system pathology and peripheral systemic insults, guiding integrative treatment approaches.
The authors do not overlook the ethical dimension of delirium research involving animals, emphasizing adherence to humane standards and refinement of experimental designs to minimize suffering while maximizing data quality. Moreover, they call for collaborative efforts across research institutions to establish shared protocols and repositories, fostering reproducibility and accelerating progress in this challenging field.
Overall, this comprehensive review by Barichello and colleagues significantly advances the field of delirium research by synthesizing current animal modeling strategies and laying out a roadmap for future endeavors. Their critical insights and forward-looking perspective are poised to catalyze new discoveries in delirium’s neurobiology, facilitate translational breakthroughs, and ultimately improve patient outcomes in this pervasive yet poorly understood neuropsychiatric syndrome.
The narrative review stands as a testament to the power of preclinical science in unraveling complex brain disorders and exemplifies the necessity of integrative, multidisciplinary approaches in contemporary neuroscience. As research continues to evolve, animal models developed and refined through such scholarship will remain indispensable tools in illuminating delirium’s mysteries and crafting the next generation of interventions capable of mitigating this medical challenge.
Subject of Research: Animal models for studying the pathophysiology and mechanisms of delirium.
Article Title: Animal models of delirium: a narrative review.
Article References:
Barichello, T., Simon, C.S., Dominguini, D. et al. (2026). Animal models of delirium: a narrative review. Transl Psychiatry. https://doi.org/10.1038/s41398-026-04071-w
Image Credits: AI Generated
